HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,865,081 | -1.8% | 318,654 | -12.7% | 0.12% | +9.5% |
| Q2 2023 | $37,552,283 | -2.9% | 365,117 | +3.1% | 0.10% | -8.7% |
| Q1 2023 | $38,660,117 | +95.6% | 354,225 | +103.9% | 0.12% | +79.7% |
| Q4 2022 | $19,768,084 | -20.1% | 173,709 | -56.6% | 0.06% | -19.0% |
| Q3 2022 | $24,751,000 | +61.2% | 399,926 | +107.8% | 0.08% | +97.5% |
| Q2 2022 | $15,353,000 | -27.9% | 192,491 | -4.9% | 0.04% | -9.1% |
| Q1 2022 | $21,291,000 | -43.0% | 202,370 | -41.6% | 0.04% | -38.9% |
| Q4 2021 | $37,339,000 | +16.6% | 346,498 | +18.6% | 0.07% | +9.1% |
| Q3 2021 | $32,012,000 | +49.6% | 292,244 | +27.9% | 0.07% | +50.0% |
| Q2 2021 | $21,394,000 | +16.9% | 228,468 | +14.9% | 0.04% | +12.8% |
| Q1 2021 | $18,308,000 | +121.3% | 198,913 | +75.9% | 0.04% | +105.3% |
| Q4 2020 | $8,272,000 | +307.3% | 113,077 | +332.5% | 0.02% | +280.0% |
| Q3 2020 | $2,031,000 | +51.2% | 26,147 | +8.2% | 0.01% | +25.0% |
| Q2 2020 | $1,343,000 | +79.5% | 24,157 | -4.3% | 0.00% | +100.0% |
| Q1 2020 | $748,000 | -21.9% | 25,247 | -4.6% | 0.00% | 0.0% |
| Q4 2019 | $958,000 | -84.8% | 26,457 | -89.9% | 0.00% | -88.9% |
| Q2 2019 | $6,287,000 | – | 261,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |